Cambridge's AI designed universal coronavirus vaccine clears its first human trial

This is what it looks like when AI moves from generating antibody predictions on a screen to actually going into someone's arm, and the fact that nothing went wrong is a bigger deal than it sounds. The real trick here is not the vaccine itself but the underlying idea, letting a model hunt for the shared vulnerabilities across an entire virus family instead of chasing whatever variant is dominant this season. It is still years from a pharmacy shelf, so the headline is proof of concept, not a cure, but it is the kind of proof that changes how the next decade of vaccine research gets funded.